Show Summary Details
Page of

Cardiac disease in HIV infection 

Cardiac disease in HIV infection
Cardiac disease in HIV infection

Peter F. Currie

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 07 March 2021

Symptomatic heart disease can affect up to 10% of HIV-positive patients and cause death in around 2%. Cardiovascular screening and risk factor management is recommended.

In resource-poor countries where access to antiretroviral drugs is limited the typical manifestations are (1) HIV heart muscle disease—this occurs in the late stages of HIV infection, with dilated cardiomyopathy having a dismal prognosis, the median survival after diagnosis being about 100 days; standard therapy for heart failure should be considered; and (2) pericardial effusion—a common finding, but most are symptomless; significant effusions are often due to mycobacterial infection or malignant infiltration, particularly with non-Hodgkin’s lymphoma.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.